Down-regulation of GABAa receptor via promiscuity with the vasoactive peptide urotensin II receptor. potential involvement in astrocyte plasticity

PLoS ONE

Volumn 7, Issue 5, 2012, Pages

  Desrues, Laurence ^a,b   Lefebvre, Thomas ^a,b   Lecointre, Céline ^a,b   Schouft, Marie Thérèse ^a,b   Leprince, Jérôme ^a,b   Compère, Vincent ^a,b,c   Morin, Fabrice ^a,b   Proust, François ^a,b,c   Gandolfo, Pierrick ^a,b   Tonon, Marie Christine ^a,b   Castel, Hélène ^a,b  

^a UNIVERSITÉ DE ROUEN   (France)

^b UNIVERSITY OF ROUEN   (France)

^c ROUEN UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; UROTENSIN RECEPTOR; CALCIUM; G PROTEIN COUPLED RECEPTOR; UROTENSIN; UROTENSIN II; UTS2R PROTEIN, HUMAN; UTS2R PROTEIN, RAT;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; BRAIN SLICE; CARBOXY TERMINAL SEQUENCE; CELL PROLIFERATION; CONTROLLED STUDY; ENDOCYTOSIS; GABAERGIC TRANSMISSION; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; IMMUNOREACTIVITY; MEMBRANE POTENTIAL; NERVE CELL PLASTICITY; NONHUMAN; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; PURKINJE CELL; RAT; SIGNAL TRANSDUCTION; SYNAPTIC TRANSMISSION; ANIMAL; CELL CULTURE; CELL MEMBRANE POTENTIAL; CEREBELLUM; CHO CELL; CRICETULUS; CYTOLOGY; DOWN REGULATION; DRUG EFFECT; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; GENETICS; HAMSTER; METABOLISM; NERVE CELL; PHYSIOLOGY; PROTEIN SUBUNIT; TUMOR CELL LINE; WISTAR RAT;

MAMMALIA; RATTUS;

ANIMALS; ASTROCYTES; CALCIUM; CELL LINE, TUMOR; CELLS, CULTURED; CEREBELLUM; CHO CELLS; CRICETINAE; CRICETULUS; DOWN-REGULATION; ENDOCYTOSIS; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; MEMBRANE POTENTIALS; NEURONAL PLASTICITY; NEURONS; PROTEIN SUBUNITS; RATS; RATS, WISTAR; RECEPTOR CROSS-TALK; RECEPTORS, G-PROTEIN-COUPLED; RECEPTORS, GABA-A; UROTENSINS;

EID: 84860470980     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0036319     Document Type: Article

References (91)

1. Takano T, Tian GF, Peng W, Lou N, Libionka W, et al. (2006) Astrocyte-mediated control of cerebral blood flow. Nature neuroscience 9: 260-267.
2. Lo EH, Rosenberg GA, (2009) The neurovascular unit in health and disease: introduction. Stroke 40: S2-3.
3. Ohab JJ, Fleming S, Blesch A, Carmichael ST, (2006) A neurovascular niche for neurogenesis after stroke. The Journal of neuroscience: the official journal of the Society for Neuroscience 26: 13007-13016.
4. Wang DD, Bordey A, (2008) The astrocyte odyssey. Prog Neurobiol 86: 342-367.
5. Abbott NJ, Ronnback L, Hansson E, (2006) Astrocyte-endothelial interactions at the blood-brain barrier. Nature reviews Neuroscience 7: 41-53.
6. Eddleston AL, (1993) Immunogenetics of autoimmune chronic active hepatitis. Gastroenterologia Japonica 28 (Suppl 4): 57-62; discussion 76-80.
7. Silver J, Miller JH, (2004) Regeneration beyond the glial scar. Nature reviews Neuroscience 5: 146-156.
8. Seifert G, Schilling K, Steinhauser C, (2006) Astrocyte dysfunction in neurological disorders: a molecular perspective. Nature reviews Neuroscience 7: 194-206.
9. Sieghart W, (2006) Structure, pharmacology, and function of GABAA receptor subtypes. Adv Pharmacol 54: 231-263.
10. Nutt DJ, Stahl SM, (2009) Searching for perfect sleep: the continuing evolution of GABAA receptor modulators as hypnotics. J Psychopharmacol 24: 1601-1612.
11. D'Hulst C, Atack JR, Kooy RF, (2009) The complexity of the GABAA receptor shapes unique pharmacological profiles. Drug Discov Today 14: 866-875.
12. Von Blankenfeld G, Trotter J, Kettenmann H, (1991) Expression and Developmental Regulation of a GABAA Receptor in Cultured Murine Cells of the Oligodendrocyte Lineage. Eur J Neurosci 3: 310-316.
13. Fraser DD, Duffy S, Angelides KJ, Perez-Velazquez JL, Kettenmann H, et al. (1995) GABAA/benzodiazepine receptors in acutely isolated hippocampal astrocytes. J Neurosci 15: 2720-2732.
14. Bureau M, Laschet J, Bureau-Heeren M, Hennuy B, Minet A, et al. (1995) Astroglial cells express large amounts of GABAA receptor proteins in mature brain. J Neurochem 65: 2006-2015.
15. Tateishi N, Shimoda T, Manako J, Katsumata S, Shinagawa R, et al. (2006) Relevance of astrocytic activation to reductions of astrocytic GABAA receptors. Brain Res 1089: 79-91.
16. Moriwaki H, Matsumoto M, Hashikawa K, Oku N, Ishida M, et al. (1998) Iodine-123-iomazenil and iodine-123-iodoamphetamine SPECT in major cerebral artery occlusive disease. J Nucl Med 39: 1348-1353.
17. Muller V, Saur D, Klutmann S, Weiller C, Rother J, et al. (2002) Experience with 123I-iomazenil SPECT in acute cerebral infarction. Nucl Med Commun 23: 1191-1196.
18. Kawabata K, Tachibana H, Sugita M, Fukuchi M, (1996) [Impairment of benzodiazepine receptor in Parkinson's disease evaluated by 123I-iomazenil SPECT]. Kaku Igaku 33: 391-397.
19. Ohyama M, Senda M, Ishiwata K, Kitamura S, Mishina M, et al. (1999) Preserved benzodiazepine receptors in Alzheimer's disease measured with C-11 flumazenil PET and I-123 iomazenil SPECT in comparison with CBF. Ann Nucl Med 13: 309-315.
20. Rissman RA, Mishizen-Eberz AJ, Carter TL, Wolfe BB, De Blas AL, et al. (2003) Biochemical analysis of GABA(A) receptor subunits alpha 1, alpha 5, beta 1, beta 2 in the hippocampus of patients with Alzheimer's disease neuropathology. Neuroscience 120: 695-704.
21. Verheul HB, de Leeuw FE, Scholten G, Tulleken CA, Lopes da Silva FH, et al. (1993) GABAA receptor function in the early period after transient forebrain ischaemia in the rat. Eur J Neurosci 5: 955-960.
22. Luhmann HJ, Mittmann T, van Luijtelaar G, Heinemann U, (1995) Impairment of intracortical GABAergic inhibition in a rat model of absence epilepsy. Epilepsy Res 22: 43-51.
23. Li H, Siegel RE, Schwartz RD, (1993) Rapid decline of GABAA receptor subunit mRNA expression in hippocampus following transient cerebral ischemia in the gerbil. Hippocampus 3: 527-537.
24. Schwartz-Bloom RD, Sah R, (2001) gamma-Aminobutyric acid(A) neurotransmission and cerebral ischemia. J Neurochem 77: 353-371.
25. Labrakakis C, Patt S, Hartmann J, Kettenmann H, (1998) Functional GABA(A) receptors on human glioma cells. Eur J Neurosci 10: 231-238.
26. Labarrere P, Chatenet D, Leprince J, Marionneau C, Loirand G, et al. (2003) Structure-activity relationships of human urotensin II and related analogues on rat aortic ring contraction. J Enzyme Inhib Med Chem 18: 77-88.
27. Sugo T, Murakami Y, Shimomura Y, Harada M, Abe M, et al. (2003) Identification of urotensin II-related peptide as the urotensin II-immunoreactive molecule in the rat brain. Biochem Biophys Res Commun 310: 860-868.
28. Douglas SA, Dhanak D, Johns DG, (2004) From 'gills to pills': urotensin-II as a regulator of mammalian cardiorenal function. Trends Pharmacol Sci 25: 76-85.
29. Liu Q, Pong SS, Zeng Z, Zhang Q, Howard AD, et al. (1999) Identification of urotensin II as the endogenous ligand for the orphan G-protein-coupled receptor GPR14. Biochem Biophys Res Commun 266: 174-178.
30. Elshourbagy NA, Douglas SA, Shabon U, Harrison S, Duddy G, et al. (2002) Molecular and pharmacological characterization of genes encoding urotensin-II peptides and their cognate G-protein-coupled receptors from the mouse and monkey. Br J Pharmacol 136: 9-22.
31. Ziltener P, Mueller C, Haenig B, Scherz MW, Nayler O, (2002) Urotensin II mediates ERK1/2 phosphorylation and proliferation in GPR14-transfected cell lines. J Recept Signal Transduct Res 22: 155-168.
32. Sauzeau V, Le Mellionnec E, Bertoglio J, Scalbert E, Pacaud P, et al. (2001) Human urotensin II-induced contraction and arterial smooth muscle cell proliferation are mediated by RhoA and Rho-kinase. Circ Res 88: 1102-1104.
33. Gong H, Wang YX, Zhu YZ, Wang WW, Wang MJ, et al. (2004) Cellular distribution of GPR14 and the positive inotropic role of urotensin II in the myocardium in adult rat. J Appl Physiol 97: 2228-2235.
34. Johns DG, Ao Z, Naselsky D, Herold CL, Maniscalco K, et al. (2004) Urotensin-II-mediated cardiomyocyte hypertrophy: effect of receptor antagonism and role of inflammatory mediators. Naunyn Schmiedebergs Arch Pharmacol 370: 238-250.
35. Shi L, Ding W, Li D, Wang Z, Jiang H, et al. (2006) Proliferation and anti-apoptotic effects of human urotensin II on human endothelial cells. Atherosclerosis 188: 260-264.
36. Watanabe T, Pakala R, Katagiri T, Benedict CR, (2001) Synergistic effect of urotensin II with mildly oxidized LDL on DNA synthesis in vascular smooth muscle cells. Circulation 104: 16-18.
37. Guidolin D, Albertin G, Oselladore B, Sorato E, Rebuffat P, et al. (2010) The pro-angiogenic activity of urotensin-II on human vascular endothelial cells involves ERK1/2 and PI3K signaling pathways. Regul Pept 162: 26-32.
38. Coulouarn Y, Lihrmann I, Jegou S, Anouar Y, Tostivint H, et al. (1998) Cloning of the cDNA encoding the urotensin II precursor in frog and human reveals intense expression of the urotensin II gene in motoneurons of the spinal cord. Proc Natl Acad Sci U S A 95: 15803-15808.
39. Coulouarn Y, Jegou S, Tostivint H, Vaudry H, Lihrmann I, (1999) Cloning, sequence analysis and tissue distribution of the mouse and rat urotensin II precursors. FEBS Lett 457: 28-32.
40. Lin Y, Tsuchihashi T, Matsumura K, Fukuhara M, Ohya Y, et al. (2003) Central cardiovascular action of urotensin II in spontaneously hypertensive rats. Hypertens Res 26: 839-845.
41. Castel H, Diallo M, Chatenet D, Leprince J, Desrues L, et al. (2006) Biochemical and functional characterization of high-affinity urotensin II receptors in rat cortical astrocytes. J Neurochem 99: 582-595.
42. Jarry M, Diallo M, Lecointre C, Desrues L, Tokay T, et al. (2010) The vasoactive peptides urotensin II and urotensin II-related peptide regulate astrocyte activity through common and distinct mechanisms: involvement in cell proliferation. Biochem J 428: 113-124.
43. Desrues L, Lefebvre T, Diallo M, Gandolfo P, Leprince J, et al. (2008) Effect of GABA A receptor activation on UT-coupled signaling pathways in rat cortical astrocytes. Peptides 29: 727-734.
44. Sotelo C, (2004) Cellular and genetic regulation of the development of the cerebellar system. Prog Neurobiol 72: 295-339.
45. Taft JR, Vertes RP, Perry GW, (2005) Distribution of GFAP+ astrocytes in adult and neonatal rat brain. Int J Neurosci 115: 1333-1343.
46. Tretter V, Ehya N, Fuchs K, Sieghart W, (1997) Stoichiometry and assembly of a recombinant GABAA receptor subtype. J Neurosci 17: 2728-2737.
47. Blair LA, Levitan ES, Marshall J, Dionne VE, Barnard EA, (1988) Single subunits of the GABAA receptor form ion channels with properties of the native receptor. Science 242: 577-579.
48. Pritchett DB, Sontheimer H, Gorman CM, Kettenmann H, Seeburg PH, et al. (1988) Transient expression shows ligand gating and allosteric potentiation of GABAA receptor subunits. Science 242: 1306-1308.
49. Sigel E, Baur R, Trube G, Mohler H, Malherbe P, (1990) The effect of subunit composition of rat brain GABAA receptors on channel function. Neuron 5: 703-711.
50. Krishek BJ, Xie X, Blackstone C, Huganir RL, Moss SJ, et al. (1994) Regulation of GABAA receptor function by protein kinase C phosphorylation. Neuron 12: 1081-1095.
51. Angelotti TP, Macdonald RL, (1993) Assembly of GABAA receptor subunits: alpha 1 beta 1 and alpha 1 beta 1 gamma 2S subunits produce unique ion channels with dissimilar single-channel properties. J Neurosci 13: 1429-1440.
52. Diallo M, Jarry M, Desrues L, Castel H, Chatenet D, et al. (2008) [Orn5]URP acts as a pure antagonist of urotensinergic receptors in rat cortical astrocytes. Peptides 29: 813-819.
53. Chatenet D, Dubessy C, Leprince J, Boularan C, Carlier L, et al. (2004) Structure-activity relationships and structural conformation of a novel urotensin II-related peptide. Peptides 25: 1819-1830.
54. Clozel M, Binkert C, Birker-Robaczewska M, Boukhadra C, Ding SS, et al. (2004) Pharmacology of the urotensin-II receptor antagonist palosuran (ACT-058362; 1-[2-(4-benzyl-4-hydroxy-piperidin-1-yl)-ethyl]-3-(2-methyl-quinolin-4-yl)-urea sulfate salt): first demonstration of a pathophysiological role of the urotensin System. J Pharmacol Exp Ther 311: 204-212.
55. Behm DJ, McAtee JJ, Dodson JW, Neeb MJ, Fries HE, et al. (2008) Palosuran inhibits binding to primate UT receptors in cell membranes but demonstrates differential activity in intact cells and vascular tissues. Br J Pharmacol 155: 374-386.
56. Puia G, Vicini S, Seeburg PH, Costa E, (1991) Influence of recombinant gamma-aminobutyric acid-A receptor subunit composition on the action of allosteric modulators of gamma-aminobutyric acid-gated Cl- currents. Mol Pharmacol 39: 691-696.
57. Wafford KA, Whiting PJ, Kemp JA, (1993) Differences in affinity and efficacy of benzodiazepine receptor ligands at recombinant gamma-aminobutyric acidA receptor subtypes. Mol Pharmacol 43: 240-244.
58. Bianchi MT, Haas KF, Macdonald RL, (2001) Structural determinants of fast desensitization and desensitization-deactivation coupling in GABAa receptors. The Journal of neuroscience: the official journal of the Society for Neuroscience 21: 1127-1136.
59. Boileau AJ, Baur R, Sharkey LM, Sigel E, Czajkowski C, (2002) The relative amount of cRNA coding for gamma2 subunits affects stimulation by benzodiazepines in GABA(A) receptors expressed in Xenopus oocytes. Neuropharmacology 43: 695-700.
60. Yoon KW, (1994) Voltage-dependent modulation of GABAA receptor channel desensitization in rat hippocampal neurons. Journal of neurophysiology 71: 2151-2160.
61. Dominguez-Perrot C, Feltz P, Poulter MO, (1996) Recombinant GABAA receptor desensitization: the role of the gamma 2 subunit and its physiological significance. The Journal of physiology 497 (Pt 1): 145-159.
62. Moss SJ, Smart TG, (1996) Modulation of amino acid-gated ion channels by protein phosphorylation. Int Rev Neurobiol 39: 1-52.
63. Brandon N, Jovanovic J, Moss S, (2002) Multiple roles of protein kinases in the modulation of gamma-aminobutyric acid(A) receptor function and cell surface expression. Pharmacol Ther 94: 113-122.
64. Kittler JT, Moss SJ, (2003) Modulation of GABAA receptor activity by phosphorylation and receptor trafficking: implications for the efficacy of synaptic inhibition. Curr Opin Neurobiol 13: 341-347.
65. Gartlon J, Parker F, Harrison DC, Douglas SA, Ashmeade TE, et al. (2001) Central effects of urotensin-II following ICV administration in rats. Psychopharmacology (Berl) 155: 426-433.
66. Jegou S, Cartier D, Dubessy C, Gonzalez BJ, Chatenet D, et al. (2006) Localization of the urotensin II receptor in the rat central nervous system. J Comp Neurol 495: 21-36.
67. Clark SD, Nothacker HP, Wang Z, Saito Y, Leslie FM, et al. (2001) The urotensin II receptor is expressed in the cholinergic mesopontine tegmentum of the rat. Brain Res 923: 120-127.
68. Pirker S, Schwarzer C, Wieselthaler A, Sieghart W, Sperk G, (2000) GABA(A) receptors: immunocytochemical distribution of 13 subunits in the adult rat brain. Neuroscience 101: 815-850.
69. Fritschy JM, Panzanelli P, (2006) Molecular and synaptic organization of GABAA receptors in the cerebellum: Effects of targeted subunit gene deletions. Cerebellum 5: 275-285.
70. Laurie DJ, Wisden W, Seeburg PH, (1992) The distribution of thirteen GABAA receptor subunit mRNAs in the rat brain. III. Embryonic and postnatal development. J Neurosci 12: 4151-4172.
71. Bovolin P, Santi MR, Puia G, Costa E, Grayson D, (1992) Expression patterns of gamma-aminobutyric acid type A receptor subunit mRNAs in primary cultures of granule neurons and astrocytes from neonatal rat cerebella. Proc Natl Acad Sci USA 89: 9344-9348.
72. McKhann GM, D'Ambrosio R, Janigro D, (1997) Heterogeneity of astrocyte resting membrane potentials and intercellular coupling revealed by whole-cell and gramicidin-perforated patch recordings from cultured neocortical and hippocampal slice astrocytes. J Neurosci 17: 6850-6863.
73. Haydar TF, Wang F, Schwartz ML, Rakic P, (2000) Differential modulation of proliferation in the neocortical ventricular and subventricular zones. J Neurosci 20: 5764-5774.
74. LoTurco JJ, Owens DF, Heath MJ, Davis MB, Kriegstein AR, (1995) GABA and glutamate depolarize cortical progenitor cells and inhibit DNA synthesis. Neuron 15: 1287-1298.
75. Nilsson M, Eriksson PS, Ronnback L, Hansson E, (1993) GABA induces Ca2+ transients in astrocytes. Neuroscience 54: 605-614.
76. Ames RS, Sarau HM, Chambers JK, Willette RN, Aiyar NV, et al. (1999) Human urotensin-II is a potent vasoconstrictor and agonist for the orphan receptor GPR14. Nature 401: 282-286.
77. Mori M, Sugo T, Abe M, Shimomura Y, Kurihara M, et al. (1999) Urotensin II is the endogenous ligand of a G-protein-coupled orphan receptor, SENR (GPR14). Biochem Biophys Res Commun 265: 123-129.
78. Nothacker HP, Wang Z, McNeill AM, Saito Y, Merten S, et al. (1999) Identification of the natural ligand of an orphan G-protein-coupled receptor involved in the regulation of vasoconstriction. Nat Cell Biol 1: 383-385.
79. Qi J, Du J, Tang X, Li J, Wei B, et al. (2004) The upregulation of endothelial nitric oxide synthase and urotensin-II is associated with pulmonary hypertension and vascular diseases in rats produced by aortocaval shunting. Heart Vessels 19: 81-88.
80. Green SA, Spasoff AP, Coleman RA, Johnson M, Liggett SB, (1996) Sustained activation of a G protein-coupled receptor via "anchored" agonist binding. Molecular localization of the salmeterol exosite within the 2-adrenergic receptor. J Biol Chem 271: 24029-24035.
81. Jakubik J, Tucek S, El-Fakahany EE, (2002) Allosteric modulation by persistent binding of xanomeline of the interaction of competitive ligands with the M1 muscarinic acetylcholine receptor. J Pharmacol Exp Ther 301: 1033-1041.
82. Ono T, Kawaguchi Y, Kudo M, Kushikata T, Hashiba E, et al. (2008) Urotensin II evokes neurotransmitter release from rat cerebrocortical slices. Neurosci Lett 440: 275-279.
83. Pryor PR, Mullock BM, Bright NA, Gray SR, Luzio JP, (2000) The role of intraorganellar Ca(2+) in late endosome-lysosome heterotypic fusion and in the reformation of lysosomes from hybrid organelles. J Cell Biol 149: 1053-1062.
84. Lin FT, Krueger KM, Kendall HE, Daaka Y, Fredericks ZL, et al. (1997) Clathrin-mediated endocytosis of the beta-adrenergic receptor is regulated by phosphorylation/dephosphorylation of beta-arrestin1. J Biol Chem 272: 31051-31057.
85. Herring D, Huang R, Singh M, Robinson LC, Dillon GH, et al. (2003) Constitutive GABAA receptor endocytosis is dynamin-mediated and dependent on a dileucine AP2 adaptin-binding motif within the beta 2 subunit of the receptor. J Biol Chem 278: 24046-24052.
86. Naga Prasad SV, Jayatilleke A, Madamanchi A, Rockman HA, (2005) Protein kinase activity of phosphoinositide 3-kinase regulates beta-adrenergic receptor endocytosis. Nat Cell Biol 7: 785-796.
87. Barnes EM Jr, (2001) Assembly and intracellular trafficking of GABAA receptors. Int Rev Neurobiol 48: 1-29.
88. Proulx CD, Simaan M, Escher E, Laporte SA, Guillemette G, et al. (2005) Involvement of a cytoplasmic-tail serine cluster in urotensin II receptor internalization. Biochem J 385: 115-123.
89. Cao W, Luttrell LM, Medvedev AV, Pierce KL, Daniel KW, et al. (2000) Direct binding of activated c-Src to the beta 3-adrenergic receptor is required for MAP kinase activation. J Biol Chem 275: 38131-38134.
90. Gandolfo P, Patte C, Leprince J, Thoumas JL, Vaudry H, et al. (1997) The stimulatory effect of the octadecaneuropeptide (ODN) on cytosolic Ca2+ in rat astrocytes is not mediated through classical benzodiazepine receptors. Eur J Pharmacol 322: 275-281.
91. Lefebvre T, Gonzalez BJ, Vaudry D, Desrues L, Falluel-Morel A, et al. (2009) Paradoxical effect of ethanol on potassium channel currents and cell survival in cerebellar granule neurons. J Neurochem 110: 976-989.